Kwame Ulmer

Kwame Ulmer serves as an Expert Resource in Larta’s Commercialization Assistance Program as well as the Principal at Ulmer Ventures, a regulatory strategy consulting firm. He brings nearly twenty years of experience evaluating medical technologies in the government and serving in senior operating roles at medical device companies.
Mr. Ulmer previously served as Vice President, Regulatory Affairs and Quality Assurance at Implant Direct, a Danaher Corporation operating company. Kwame has served in progressive leadership roles at the US Food and Drug Administration (FDA) and personally evaluated over 1,000 medical technologies.
Mr. Ulmer is also a Venture Partner at Wavemaker Three-Sixty Health – the leading Southern-California based, early stage venture capital firm (Seed and Series A) focused on the healthcare industry, member of the Executive Committee of Tech Coast Angels (LA), the world’s largest angel investing network, and a member of the steering committee for ScaleLA, the leading healthcare innovation space in Los Angeles. Kwame earned his B.S. in Physics from Lincoln University (Pennsylvania) and both an M.S. in Materials Engineering and M.B.A. from the University of Virginia.